SOPHIA EVANS: Open Payments
NPI 1508581075 · OLANTA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$624 in 36 payments from 11 companies in 2025. Trend: 2023 $226 · 2024 $422 · 2025 $624
Food & beverage: $624
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 12 | $219 |
| Abbott Laboratories | 6 | $96 |
| Novartis Pharmaceuticals Corporation | 5 | $79 |
| Corcept Therapeutics | 4 | $60 |
| Insulet Corporation | 2 | $50 |
| Lilly USA, LLC | 2 | $28 |
| Teleflex LLC | 1 | $26 |
| Exact Sciences Corporation | 1 | $20 |
| Stryker Corporation | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $14 |
Products named: OTEZLA, FREESTYLE LIBRE 3, LEQVIO, Korlym, Omnipod, REPATHA, BARRIGEL, Cologuard Collection Kit.
Industry payments across SC — which companies pay providers there.
